Company / Depreciation & Amortization
Chemed Corp. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$64.8M
FY2025
5-year range
$59.1M / $64.8M
FY2021-FY2025
Trend
+2.8%
vs FY2024
Sector context
#70 of 135
Health Care
What the data says
At $65M, Chemed Corp.'s depreciation & amortization ranks #66 of 135 in the Health Care sector. Depreciation & Amortization has increased for 9 consecutive years, from $35M in FY2016 to $65M in FY2025.
Based on SEC 10-K filings.
$65M in FY2025 with a 5-year CAGR of +2.8%.
Increased from $61M to $65M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +2.8%
- 10-Year CAGR
- -
Sector benchmark
#66 of 135 in Health CareTop 48% of 135This company $64.8M Sector average $334.5M
▼
-80.6% below sector average
Key checks
Key Insights
- Chemed Corp.'s depreciation & amortization has grown for 9 consecutive years.
- 5-year CAGR of +2.8%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 2.8% year-over-year.
- Ranks #70 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.8M | +2.8% |
| FY2024 | $63.0M | +3.6% |
| FY2023 | $60.9M | +2.9% |
| FY2022 | $59.2M | +0.2% |
| FY2021 | $59.1M | +4.4% |
| FY2020 | $56.6M | +25.2% |
| FY2019 | $45.2M | +16.3% |
| FY2018 | $38.9M | +9.1% |
| FY2017 | $35.6M | +2.8% |
| FY2016 | $34.6M | +3.4% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026